Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

xellia pharmaceuticals usa llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin and sulbactam for injection, usp is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus , escherichia coli ,2 klebsiella spp.2 (including k. pneumoniae2 ), proteus mirabilis ,2 bacteroides fragilis ,2 enterobacter spp.,2 and acinetobacter calcoaceticus.2 note: for information on use in pediatric patients (see precautions-pediatric use and clinical studies sections). intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli , klebsiella spp. (including k. pneumoniae2 ), bacteroides spp. (including b. fragilis ), and enterobacter spp.2 gynecological infections caused by beta-lactamase producing strains of escherichia coli,2 and bacteroides spp.2 (including b. fragilis2 ). while ampicillin and sulbactam for injection, usp is indicated only for the conditions listed above, infe

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

xellia pharmaceuticals usa llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin and sulbactam for injection, usp is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus , escherichia coli ,2 klebsiella spp.2 (including k. pneumoniae2 ), proteus mirabilis ,2 bacteroides fragilis ,2 enterobacter spp.,2 and acinetobacter calcoaceticus.2 note: for information on use in pediatric patients (see precautions–pediatric use and clinical studies sections). intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli , klebsiella spp. (including k. pneumoniae2 ), bacteroides spp. (including b. fragilis ), and enterobacter spp.2 gynecological infections caused by beta-lactamase producing strains of escherichia coli,2 and bacteroides spp.2 (including b. fragilis2 ). while ampicillin and sulbactam for injection, usp is indicated only for the conditions listed above

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

eugia us llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin and sulbactam for injection is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus , escherichia coli ,* klebsiella spp.* (including k. pneumoniae * ), proteus mirabilis ,* bacteroides fragilis ,* enterobacter spp.,* and acinetobacter calcoaceticus .* note: for information on use in pediatric patients (see precautions–pediatric use and clinical studies sections). intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli , klebsiella spp. (including k. pneumoniae * ), bacteroides spp. (including b. fragilis ), and enterobacter spp.*  gynecological infections caused by beta-lactamase producing strains of escherichia coli ,* and bacteroides spp.* (including b. fragilis * ). *  efficacy for this organism in this organ system was studied in

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

eugia us llc - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin and sulbactam for injection, usp is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus , escherichia coli ,*klebsiella spp.* (including k. pneumoniae *), proteus mirabilis ,*bacteroides fragilis ,*enterobacter spp.,* and acinetobacter calcoaceticus .* note: for information on use in pediatric patients (see precautions–pediatric use and clinical studies sections). intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli , klebsiella spp. (including k. pneumoniae *), bacteroides spp. (including b. fragilis ), and enterobacter spp.* gynecological infections caused by beta-lactamase producing strains of escherichia coli ,* and bacteroides spp.* (including b. fragilis *). *  efficacy for this organism in this organ system was studied in fewer than

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

armas pharmaceuticals inc. - ampicillin sodium (unii: jfn36l5s8k) (ampicillin - unii:7c782967rd), sulbactam sodium (unii: dkq4t82ye6) (sulbactam - unii:s4tf6i2330) - ampicillin and sulbactam for injection is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. skin and skin structure infections caused by beta-lactamase producing strains of staphylococcus aureus , escherichia coli ,* klebsiella spp.* (including k. pneumoniae* ), proteus mirabilis ,* bacteroides fragilis ,* enterobacter spp.,* and acinetobacter calcoaceticus.* note: for information on use in pediatric patients (see precautions– pediatric use and clinical studies sections). intra-abdominal infections caused by beta-lactamase producing strains of escherichia coli , klebsiella spp. (including k. pneumoniae* ), bacteroides spp. (including b. fragilis ), and enterobacter spp.* gynecological infections caused by beta-lactamase producing strains of escherichia coli,* and bacteroides spp.* (including b. fragilis* ). * efficacy for this organism in this or

Kanada - Inggeris - Health Canada

fresenius kabi canada ltd - ampicillin (ampicillin sodium) - powder for solution - 2g - ampicillin (ampicillin sodium) 2g - aminopenicillins

Kanada - Inggeris - Health Canada

fresenius kabi canada ltd - ampicillin (ampicillin sodium) - powder for solution - 1g - ampicillin (ampicillin sodium) 1g - aminopenicillins

Kanada - Inggeris - Health Canada

fresenius kabi canada ltd - ampicillin (ampicillin sodium) - powder for solution - 500mg - ampicillin (ampicillin sodium) 500mg - aminopenicillins

Kanada - Inggeris - Health Canada

fresenius kabi canada ltd - ampicillin (ampicillin sodium) - powder for solution - 250mg - ampicillin (ampicillin sodium) 250mg - aminopenicillins

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

denton pharma, inc. dba northwind pharmaceuticals - ampicillin trihydrate (unii: hxq6a1n7r6) (ampicillin - unii:7c782967rd) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of ampicillin capsules, ampicillin for oral suspension and other antibacterial drugs, ampicillin capsules and ampicillin for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. when culture and susceptibility information are available, they should be considered in selecting of modifying antimicrobial therapy, in the absence of such data, local epidemiology and susceptibility patterns contribute to the empiric selection of therapy. ampicillin capsules and ampicillin for oral suspension are indicated in the treatment of infections caused by susceptible strains of the designated organisms listed below: infections of the genitourinary tract including gonorrhea: e. coli, p. mirabilis, enterococci , shigella, s. typhosa and other salmonella , and nonpenicillinase producing n. gonorrhoeae . infections of the respirat